These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2644339)

  • 21. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
    Byerley WF; Reimherr FW; Wood DR; Grosser BI
    J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE; Lyle FA; Higginbotham W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative trial of fluoxetine versus trazodone in outpatients with major depression.
    Perry PJ; Garvey MJ; Kelly MW; Cook BL; Dunner FJ; Winokur G
    J Clin Psychiatry; 1989 Aug; 50(8):290-4. PubMed ID: 2668259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trazodone, a triazolopyridine derivative, in primary depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1980 Jul; 41(7):250-5. PubMed ID: 6993447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.
    Simon GE; Heiligenstein JH; Grothaus L; Katon W; Revicki D
    J Clin Psychiatry; 1998 Feb; 59(2):49-55. PubMed ID: 9501885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.
    Feighner JP; Boyer WF; Merideth CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Apr; 4(2):127-34. PubMed ID: 2663975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative trial of a new antidepressant, fluoxetine.
    Levine S; Deo R; Mahadevan K
    Br J Psychiatry; 1987 May; 150():653-5. PubMed ID: 3307982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression.
    Stratta P; Bolino F; Cupillari M; Casacchia M
    Int Clin Psychopharmacol; 1991; 6(3):193-6. PubMed ID: 1806625
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder.
    Cohn JB; Collins G; Ashbrook E; Wernicke JF
    Int Clin Psychopharmacol; 1989 Oct; 4(4):313-22. PubMed ID: 2607128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy of nomifensine and imipramine.
    Woggon B; Angst J
    Psychopharmacol Bull; 1979 Jul; 15(3):29-31. PubMed ID: 386407
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind comparative study: amineptine (Survector 100) versus imipramine.
    Mendis N; Hanwella DR; Weerasinghe C; Illesinghe DS; De Silva D
    Clin Neuropharmacol; 1989; 12 Suppl 2():S58-65. PubMed ID: 2698272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The introductory placebo washout: a retrospective evaluation.
    Reimherr FW; Ward MF; Byerley WF
    Psychiatry Res; 1989 Nov; 30(2):191-9. PubMed ID: 2694202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.